Auriga Reiterates Buy, $17 Target on NutriSystem

Auriga maintains its Buy rating and price target of $17 on NutriSystem (NASDAQ: NTRI) as it sees entry opportunity in the company shares' recent pullback, which is potentially driven on lack of promotion.

Auriga says, "Investors Should Not Panic Over Limited Nutrisystem Promotion. While we are also concerned about and are monitoring Nutrisystem's price promotions, we do not view the current promotion as being in the same league as last year's first quarter. Last year, Nutrisystem's aggressive discounts were system wide, being advertised similarly across all its advertising outlets, and lasted from late January until the end of March. The current promotion that seems to have caused investor concern, targets the Core 4-week offering with a 50% discount on the first month's purchase."

NTRI closed at $12.56 a share on Tuesday.